London Daily

Focus on the big picture.
Friday, Aug 22, 2025

Single-dose J&J Covid vaccine formally approved in the UK by drugs regulator

Single-dose J&J Covid vaccine formally approved in the UK by drugs regulator

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved the use of Johnson & Johnson’s single-dose Covid-19 jab, adding a fourth coronavirus vaccine to the country’s inoculation programme.
The British government has so far ordered 20 million doses of the vaccine from Janssen, a division of J&J, set to arrive later this year, with the jab having shown 85% effectiveness in preventing severe Covid-related illness during manufacturer Janssen’s trials.

“The Janssen vaccine will be another weapon in our arsenal to beat this pandemic,” vaccine deployment minister, Nadhim Zahawi, said following the approval.

The government has not yet outlined details of who will receive the vaccine, with the Joint Committee on Vaccination and Immunisation (JCVI) set to provide that guidance shortly.

Johnson & Johnson's Janssen jab joins the Oxford-AstraZeneca, Pfizer-BioNTech, and Moderna vaccines in the UK’s inoculation line-up, adding what Health Secretary Matt Hancock called a “further boost” to its “hugely successful” rollout.

Due to the ability to easily store and transport the Johnson & Johnson vaccine, as it can be stored at fridge temperature, it could help to boost the existing vaccination campaign by providing for individuals who can’t travel to inoculation centres.

Janssen’s Covid vaccine had already been approved for use by the European Medicines Agency (EMA), the US' Food and Drug Administration (FDA) and the World Health Organization (WHO), though the EMA is currently in the process of investigating the death of a Belgian woman who'd received the jab.

The rollout of J&J's Janssen jab had previously been paused in America, the EU and South Africa, after reports of rare blood clots in a small number of US recipients. However, after an analysis of the risk-versus-benefit data of the jab, states resumed its usage and the pharma firm proceeded with dose deliveries.
Newsletter

Related Articles

0:00
0:00
Close
After 200,000 Orders in 2 Minutes: Xiaomi Accelerates Marketing in Europe
Ukraine Declares De Facto War on Hungary and Slovakia with Terror Drone Strikes on Their Gas Lifeline
Animated K-pop Musical ‘KPop Demon Hunters’ Becomes Netflix’s Most-Watched Original Animated Film
New York Appeals Court Voids Nearly $500 Million Civil Fraud Penalty Against Trump While Upholding Fraud Liability
Elon Musk tweeted, “Europe is dying”
Far-Right Activist Convicted of Incitement Changes Gender and Demands: "Send Me to a Women’s Prison" | The Storm in Germany
Hungary Criticizes Ukraine: "Violating Our Sovereignty"
Will this be the first country to return to negative interest rates?
Child-free hotels spark controversy
North Korea is where this 95-year-old wants to die. South Korea won’t let him go. Is this our ally or a human rights enemy?
Hong Kong Launches Regulatory Regime and Trials for HKD-Backed Stablecoins
China rehearses September 3 Victory Day parade as imagery points to ‘loyal wingman’ FH-97 family presence
Trump Called Viktor Orbán: "Why Are You Using the Veto"
Horror in the Skies: Plane Engine Exploded, Passengers Sent Farewell Messages
MSNBC Rebrands as MS NOW Amid Comcast’s Cable Spin-Off
AI in Policing: Draft One Helps Speed Up Reports but Raises Legal and Ethical Concerns
Shame in Norway: Crown Princess’s Son Accused of Four Rapes
Apple Begins Simultaneous iPhone 17 Production in India and China
A Robot to Give Birth: The Chinese Announcement That Shakes the World
Finnish MP Dies by Suicide in Parliament Building
Outrage in the Tennis World After Jannik Sinner’s Withdrawal Storm
William and Kate Are Moving House – and the New Neighbors Were Evicted
Class Action Lawsuit Against Volkswagen: Steering Wheel Switches Cause Accidents
Taylor Swift on the Way to the Super Bowl? All the Clues Stirring Up Fans
Dogfights in the Skies: Airbus on Track to Overtake Boeing and Claim Aviation Supremacy
Tim Cook Promises an AI Revolution at Apple: "One of the Most Significant Technologies of Our Generation"
Apple Expands Social Media Presence in China With RedNote Account Ahead of iPhone 17 Launch
Are AI Data Centres the Infrastructure of the Future or the Next Crisis?
Cambridge Dictionary Adds 'Skibidi,' 'Delulu,' and 'Tradwife' Amid Surge of Online Slang
Bill Barr Testifies No Evidence Implicated Trump in Epstein Case; DOJ Set to Release Records
Zelenskyy Returns to White House Flanked by European Allies as Trump Pressures Land-Swap Deal with Putin
The CEO Who Replaced 80% of Employees for the AI Revolution: "I Would Do It Again"
Emails Worth Billions: How Airlines Generate Huge Profits
Character.ai Bets on Future of AI Companionship
China Ramps Up Tax Crackdown on Overseas Investments
Japanese Office Furniture Maker Expands into Bomb Shelter Market
Intel Shares Surge on Possible U.S. Government Investment
Hurricane Erin Threatens U.S. East Coast with Dangerous Surf
EU Blocks Trade Statement Over Digital Rule Dispute
EU Sends Record Aid as Spain Battles Wildfires
JPMorgan Plans New Canary Wharf Tower
Zelenskyy and his allies say they will press Trump on security guarantees
Beijing is moving into gold and other assets, diversifying away from the dollar
Escalating Clashes in Serbia as Anti-Government Protests Spread Nationwide
The Drought in Britain and the Strange Request from the Government to Delete Old Emails
Category 5 Hurricane in the Caribbean: 'Catastrophic Storm' with Winds of 255 km/h
"No, Thanks": The Mathematical Genius Who Turned Down 1.5 Billion Dollars from Zuckerberg
The surprising hero, the ugly incident, and the criticism despite victory: "Liverpool’s defense exposed in full"
Digital Humans Move Beyond Sci-Fi: From Virtual DJs to AI Customer Agents
YouTube will start using AI to guess your age. If it’s wrong, you’ll have to prove it
×